November 20, 2024

CPPD Disease: More Common Than Previously Thought

In a paradigm shift for treating acute CPPD crystal arthritis, the 2023 COLCHICORT trial showed prednisone matched colchicine's efficacy with better tolerability in older patients, challenging long-held treatment assumptions.

Conexiant

November 20, 2024

CPPD Disease: More Common Than Previously Thought

In a paradigm shift for treating acute CPPD crystal arthritis, the 2023 COLCHICORT trial showed prednisone matched colchicine's efficacy with better tolerability in older patients, challenging long-held treatment assumptions.

Conexiant

November 19, 2024

Can Fluid Restriction Stop MDMA Hyponatremia?

A 433% oxytocin increase—not vasopressin—correlated with MDMA-induced hyponatremia, with fluid restriction preventing all cases in a controlled setting.

Conexiant

November 19, 2024

Art-Based Training Improves Neurology Observational Skills

Conexiant

November 19, 2024

Can High Dose Buprenorphine Improve Fentanyl OUD Outcomes?

Conexiant

November 18, 2024

Bladder Anticholinergics Tied to Dementia Risk

Conexiant

November 15, 2024

RFK Jr.'s Vision for U.S. Food and Drug System Reform

The FDA's nutrition department has to go: "They're not doing their job. They're not protecting our kids."

Reuters

November 15, 2024

Teen Snoring Tied to Behavioral Concerns

Teen snoring, especially in obesity, links to behavioral issues but spares cognition—'Habitual snorers showed no cognitive deficits but elevated CBCL scores'

Conexiant

November 15, 2024

Global Study Finds Pruritus Affects 40% of Adults Worldwide

Patients with skin conditions are three times more likely to experience pruritus, highlighting a critical link between dermatologic health and quality of life.

Conexiant